Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-26 · accession 0001193125-26-083587 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-02-27 | 2026-02-26 | AXSM | Coleman Mark | Dir | S - Sale | $161.11 | -25.0K | 47.1K | -35% | -$4.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | S | D | 25,000 | $161.11 | 47,140 | D | — | — | (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $160.33 and $162.26. |